Company intelligence / Profile preview

General Innovations and Goods

Bexley/Columbus, Ohio, USApitchbook.com ↗

Ownership: Private
Employees: ~5
Development stage: Other

Overview

The company’s patented air purification device CREON2000A has undergone a Phase II multicenter, double-blind, randomized controlled trial to assess its effectiveness in improving asthma control and reducing events in children with mild to moderate allergic asthma. Preliminary results from SBIR-funded studies were promising enough to warrant further investigation[4].

The product uses UV light air purification combined with HEPA filtration[6].

No published commercial or pivotal clinical outcomes are available.

Therapeutic areas: Pulmonology
Modalities: Device (Air Purification System)
Industry: Therapeutic Medical Devices

Partnerships

National Institutes of Health / NIAID (SBIR funding partner)

Beyond the preview

Go deeper on General Innovations and Goods.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on General Innovations and Goods.

Explore the full profile